(Q45396691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

3

K Ardeshna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

8

D C Linch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

7

A H Goldstone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

K J Thomson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

I Kayani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

R Hough

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

A Virchis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

K S Peggs

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

8 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

1419-1422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23135356%20AND%20SRC:MED&resulttype=core&format=json

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318

High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.318